Trial · NCT03493607
Results by group97
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 97
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Adverse Events | AMO-01 | 19 | events | ||
| Number of Weekly Seizure Counts | Participants With Phelan-McDermid Syndrome (PMS) at Baseline | 22.6 | Standard Deviation 42.9 | seizure event | |
| Number of Weekly Seizure Counts | Participants With Phelan-McDermid Syndrome (PMS) at Week 1 | 4.3 | Standard Deviation 7.8 | seizure event | |
| Number of Weekly Seizure Counts | Participants With Phelan-McDermid Syndrome (PMS) at Week 2 | 15.8 | Standard Deviation 37.3 | seizure event | |
| Number of Weekly Seizure Counts | Participants With Phelan-McDermid Syndrome (PMS) at Week 4 | 14.3 | Standard Deviation 33.2 | seizure event | |
| Change in CGI - Improvement and Severity Scale | Participants With Phelan-McDermid Syndrome (PMS) at Baseline | Improvement | 0 | Standard Deviation 0 | score on a scale |
| Change in CGI - Improvement and Severity Scale | Participants With Phelan-McDermid Syndrome (PMS) at Week 1 | Improvement | 0.83 | Standard Deviation 0.98 | score on a scale |
| Change in CGI - Improvement and Severity Scale | Participants With Phelan-McDermid Syndrome (PMS) at Week 2 | Improvement | 1 | Standard Deviation 1.1 | score on a scale |
| Change in CGI - Improvement and Severity Scale | Participants With Phelan-McDermid Syndrome (PMS) at Week 4 | Improvement | 1 | Standard Deviation 0.89 | score on a scale |
| Change in CGI - Improvement and Severity Scale | Participants With Phelan-McDermid Syndrome (PMS) at Baseline | Severity | 5.33 | Standard Deviation 0.82 | score on a scale |
| Change in CGI - Improvement and Severity Scale | Participants With Phelan-McDermid Syndrome (PMS) at Week 1 | Severity | 5.33 | Standard Deviation 0.82 | score on a scale |
| Change in CGI - Improvement and Severity Scale | Participants With Phelan-McDermid Syndrome (PMS) at Week 2 | Severity | 5.33 | Standard Deviation 0.82 | score on a scale |
| Change in CGI - Improvement and Severity Scale | Participants With Phelan-McDermid Syndrome (PMS) at Week 4 | Severity | 5.17 | Standard Deviation 0.75 | score on a scale |
| Clinician-completed PMS Domain Specific Causes for Concerns Visual Analogue Scale (VAS) | Participants With Phelan-McDermid Syndrome (PMS) at Baseline | Speech | 86.83 | Standard Deviation 8.13 | score on a scale |
| Clinician-completed PMS Domain Specific Causes for Concerns Visual Analogue Scale (VAS) | Participants With Phelan-McDermid Syndrome (PMS) at Week 1 | Speech | 84.33 | Standard Deviation 5.89 | score on a scale |
| Clinician-completed PMS Domain Specific Causes for Concerns Visual Analogue Scale (VAS) | Participants With Phelan-McDermid Syndrome (PMS) at Week 2 | Speech | 84.17 | Standard Deviation 5.85 | score on a scale |
| Clinician-completed PMS Domain Specific Causes for Concerns Visual Analogue Scale (VAS) | Participants With Phelan-McDermid Syndrome (PMS) at Week 4 | Speech | 81.67 | Standard Deviation 6.06 | score on a scale |
| Clinician-completed PMS Domain Specific Causes for Concerns Visual Analogue Scale (VAS) | Participants With Phelan-McDermid Syndrome (PMS) at Baseline | Thinking and Learning | 86.67 | Standard Deviation 6.83 | score on a scale |
| Clinician-completed PMS Domain Specific Causes for Concerns Visual Analogue Scale (VAS) | Participants With Phelan-McDermid Syndrome (PMS) at Week 1 | Thinking and Learning | 77.5 | Standard Deviation 9.87 | score on a scale |
| Clinician-completed PMS Domain Specific Causes for Concerns Visual Analogue Scale (VAS) | Participants With Phelan-McDermid Syndrome (PMS) at Week 2 | Thinking and Learning | 81.67 | Standard Deviation 6.83 | score on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03493607/results